BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 38435791)

  • 1. Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling.
    Chi C; Knight WE; Riching AS; Zhang Z; Tatavosian R; Zhuang Y; Moldovan R; Rachubinski AL; Gao D; Xu H; Espinosa JM; Song K
    iScience; 2023 Jul; 26(7):107012. PubMed ID: 37360690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell models for Down syndrome-Alzheimer's disease research.
    Wu Y; West NR; Bhattacharyya A; Wiseman FK
    Neuronal Signal; 2022 Apr; 6(1):NS20210054. PubMed ID: 35449591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics and Molecular Basis of Congenital Heart Defects in Down Syndrome: Role of Extracellular Matrix Regulation.
    Mollo N; Scognamiglio R; Conti A; Paladino S; Nitsch L; Izzo A
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trisomy 21 Alters Cell Proliferation and Migration of iPSC-Derived Cardiomyocytes on Type VI Collagen.
    Reeser RS; Salazar AK; Prutton KM; Roede JR; VeDepo MC; Jacot JG
    Cell Mol Bioeng; 2024 Feb; 17(1):25-34. PubMed ID: 38435791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the pathobiology of Down syndrome--hyaluronan synthase-2 overexpression is regulated by collagen VI α2 chain.
    Karousou E; Stachtea X; Moretto P; Viola M; Vigetti D; D'Angelo ML; Raio L; Ghezzi F; Pallotti F; De Luca G; Karamanos NK; Passi A
    FEBS J; 2013 May; 280(10):2418-30. PubMed ID: 23452080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen type VI expression during cardiac development and in human fetuses with trisomy 21.
    Gittenberger-de Groot AC; Bartram U; Oosthoek PW; Bartelings MM; Hogers B; Poelmann RE; Jongewaard IN; Klewer SE
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Dec; 275(2):1109-16. PubMed ID: 14613310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of type VI collagen in the developing mouse heart.
    Klewer SE; Krob SL; Kolker SJ; Kitten GT
    Dev Dyn; 1998 Mar; 211(3):248-55. PubMed ID: 9520112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down Syndrome Related Muscle Hypotonia: Association with COL6A3 Functional SNP rs2270669.
    Dey A; Bhowmik K; Chatterjee A; Chakrabarty PB; Sinha S; Mukhopadhyay K
    Front Genet; 2013; 4():57. PubMed ID: 23626599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP2 expression in the endocardial lineage is required for AV endocardial cushion maturation and remodeling.
    Saxon JG; Baer DR; Barton JA; Hawkins T; Wu B; Trusk TC; Harris SE; Zhou B; Mishina Y; Sugi Y
    Dev Biol; 2017 Oct; 430(1):113-128. PubMed ID: 28790014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopment in Down syndrome: Concordance in humans and models.
    Klein JA; Haydar TF
    Front Cell Neurosci; 2022; 16():941855. PubMed ID: 35910249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells.
    Li J; Feng X; Wei X
    Stem Cell Res Ther; 2022 Jun; 13(1):232. PubMed ID: 35659761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycans modulate long-range mechanical communication between cells in collagen networks.
    Chen X; Chen D; Ban E; Toussaint KC; Janmey PA; Wells RG; Shenoy VB
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2116718119. PubMed ID: 35394874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.
    Tang XY; Xu L; Wang J; Hong Y; Wang Y; Zhu Q; Wang D; Zhang XY; Liu CY; Fang KH; Han X; Wang S; Wang X; Xu M; Bhattacharyya A; Guo X; Lin M; Liu Y
    J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33945512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down syndrome iPSC model: endothelial perspective on tumor development.
    Perepitchka M; Galat Y; Beletsky IP; Iannaccone PM; Galat V
    Oncotarget; 2020 Sep; 11(36):3387-3404. PubMed ID: 32934781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges.
    Parrotta EI; Lucchino V; Scaramuzzino L; Scalise S; Cuda G
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575374
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.